AI assistant
Sending…
STAAR SURGICAL CO — Director's Dealing 2021
May 18, 2021
31996_dirs_2021-05-18_38954478-5af1-448c-b496-d62f409ad16b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2021-05-17
Reporting Person: FARRELL STEPHEN C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-17 | Common Stock | M | 5328 | $7.14 | Acquired | 11136 | Direct |
| 2021-05-17 | Common Stock | D | 5328 | $113.87 | Disposed | 5808 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-17 | Common Stock Options | $7.14 | M | 5328 | Disposed | 2025-12-31 | Common Stock (5328) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.86 to $117.81, inclusive.
More from STAAR SURGICAL CO
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
May 12
Annual Report
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Proxy Solicitation & Information Statement
2026
May 4
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 20
Regulatory Filings
2026
Apr 8
Major Shareholding Notification
2026
Mar 27